How Proactive Can You Be with Eye Care?

how-proactive-can-you-be-with-eye-care.pnghow-proactive-can-you-be-with-eye-care.pngMarch is dedicated as National Nutrition Month and Save Your Vision Month, and as an organization, EyePromise® is heavily focused on the importance of nutrition and proactive eye care. Catching eye health concerns and beginning care early always leads to better patient outcomes. Nutrition is an important piece of most if not all early care plans, but how early can eye care professionals begin nutritional intervention? With EyePromise Screen Shield™ Teen, the answer is as young as 4 years old.

Introducing Screen Shield Teen

EP-SST-Bottle-Mock-Back-850x850.png EyePromise worked with our Scientific Advisory board of ODs and MDs to create Screen Shield Teen. This daily, chewable eye health nutraceutical is formulated for children ages 4 to 17 and designed to complement a daily multi-vitamin. Screen Shield Teen is:
  • Made with high-quality, all-natural zeaxanthin (not synthetic)
  • Fruit punch flavored
  • GMO free
  • Gluten free
  • The first children’s screen time eye health nutraceutical available in the doctor channel

Why Screen Shield Teen?

Today’s youth spend copious amounts of time staring at digital screens. Starting as young as 8 months old, screen time only increases with age. This increased screen time has led to 70% of children experiencing symptoms like tired eyes, headaches, and eye strain. With 69% of kids unlikely to change their screen time usage, parents worry about the lasting affects digital devices might have on their children. Screen Shield Teen gives eye care professionals a solution for these concerns.

Where Can You Get It?

Though it is not available for bulk order yet, you can preorder EyePromise Screen Shield Teen for your practice. Call EyePromise Customer Support at 866-833-2800 to preorder your case now and start naturally defending children’s eyes from the effects of screen time.

https://www.lvcenter4sight.com/how-proactive-can-you-be-with-eye-care/

Comments

Post a Comment

Popular posts from this blog

Week in review: Pay raise, Von’s Vision, gonio-<em>what?</em>

Image
APR 13, 2018 By Anni Griswold Comprehensive Ophthalmology, Cornea/External Disease, Glaucoma, Pediatric Ophth/Strabismus Above: The GonioPEN (Credit: Nanyang Technological University) A weekly roundup of ophthalmic news from around the web. Ophthalmologists earn more than the average physician , and their salaries are on the rise (+3% over the last year, to be precise). Eye docs will earn a mean $375,000 this year—more than the physician average of $299,000, but well below a typical plastic surgeon’s paycheck. See for yourself in Medscape’s 2018 Physician Compensation Report . Medscape A special supplement to USA Today will highlight the work of Von Miller , a 28-year-old linebacker for the Denver Broncos and former Super Bowl MVP. Through his foundation, Von’s Vision, Miller connects thousands of underprivileged children in Denver with affordable, high-quality eye care. His interview will appear in the “Vision Health” campaign during World Glaucoma Week, available in pr...
Read more

Patch with Microneedles Could Replace Eye Injections

Image
Instead of getting eye injections, patients with serious eye diseases may be eligible for a contact lens-type patch. 1 Injections are often recommended for eye diseases such as Wet (advanced) Age-Related Macular Degeneration, macular edema, and glaucoma. The new patch is inserted painlessly like a contact lens. It delivers tiny microneedles containing medication. The microneedles are made from natural materials and dissolve over time, gradually releasing medicine. Patients would be more likely to stick with a regimen that does not involve eye injections. Eye Injections: Stick a Needle in My Eye Patients generally dread eye injections. Injections must be performed in a doctor’s office. Eye injections can be painful, and they are inconvenient. They can introduce infection. And they can damage the eye. Avastin, Eylea, and Lucentis are injectable medications that discourage new blood vessel growth. These anti-VEGF medicines are useful for advanced Macular Degeneration , Diabetic Retino...
Read more

Lacrimal intubation improves optical quality in patients with epiphora

JAN 19, 2018 The first prospective study to evaluate the visual function and optical quality in patients with epiphora before and after lacrimal surgery. Study design This prospective study investigated functional visual acuity, higher order aberrations, lower tear meniscus and tear clearance in 30 patients (34 eyes) who underwent lacrimal passage intubation by a single surgeon. All patients had a canalicular obstruction, nasolacrimal duct obstruction or partial nasolacrimal duct obstruction. Outcomes Investigators observed significant improvements in visual function as shown by improved functional visual acuity and visual maintenance ratio. There was a significant decrease in tear meniscus dimension, which correlated with decreased blinking frequency. Optical quality significantly improved as indicated by a decrease in coma-like aberrations, spherical-like aberrations and total higher order aberrations. Stability index increased and fluctuation index decreased. Limitatio...
Read more